Coloma Jason V
Maze Therapeutics, Inc. · Chief Executive Officer
Coloma Jason V is listed in filings as Chief Executive Officer at Maze Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 3, 2026, including sale activity. Recent filings connect the profile to Maze Therapeutics, Inc. (MAZE). The current snapshot covers public activity from Sep 24, 2025 to Jun 3, 2026. Reported amounts are shown as $159.5K to $665.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $160k6.1k shares | SellJun 1, 2026 | $26.20 | $27.17 | |
| $15k553 shares | SellJun 1, 2026 | $26.24 | $27.17 |